Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease
about
Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain.Highly Selective Cyclooxygenase-1 Inhibitors P6 and Mofezolac Counteract Inflammatory State both In Vitro and In Vivo Models of Neuroinflammation.Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future.
P2860
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease
@ast
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease
@en
type
label
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease
@ast
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease
@en
prefLabel
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease
@ast
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease
@en
P2093
P2860
P50
P921
P3181
P356
P1476
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease
@en
P2093
Cristina Pomilio
Erika Fornasari
Hasan Türkez
Laura S Cerasa
Lisa Marinelli
Marcella Reale
Piera Eusepi
P2860
P3181
P356
10.3390/IJMS17071035
P407
P577
2016-06-30T00:00:00Z